Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial

Autor: Perry B. Hudson, J. Waldstreicher, H. A. Guess, Gerald L. Andriole, L. Patterson, N. A. Romas, Jonathan I. Epstein, C. L. Jackson, T. J. Cook, E. D. Crawford, D. Kadmon, H. Wise

Publikováno v: Urology. 52:195-202

Objectives. To evaluate prostate cancer detection and prostate-specific antigen (PSA) among men with benign prostatic hyperplasia treated with finasteride. Methods. Three thousand forty men 45 to 78 years of age with PSA less than 10 ng/mL and no his

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::784f2b29dbe3558a66b13ed994622397
https://doi.org/10.1016/s0090-4295(98)00184-8

Zobrazit plný text záznamu

Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment: A European Part of International survey

Autor: Kav, S. Fernadez-Ortega, P. Suominen, T. Olsen, P. R. and Patiraki, E. Porock, D. Toliusiene, J. Tadic, D. Kadmon, I. Rittenberg, J. Johnson, C.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::14307842b8c4ce0f777274f3c8c3a1dc
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3117849

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression

Autor: M R, Shaker, G, Yang, T L, Timme, S H, Park, D, Kadmon, C, Ren, X, Ji, H M, Lee, I, Sehgal, M, Anzano, M B, Sporn, T C, Thompson

Publikováno v: Clinicalexperimental metastasis. 18(5)

The effects of the synthetic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) on prostate cancer metastasis in vivo were evaluated in the mouse prostate reconstitution (MPR) model. MPRs were produced by infection of either heterozygous (+/-) or nulliz

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4dfe382318ccf4d1ec026251eb0b4e71
https://pubmed.ncbi.nlm.nih.gov/11467776

Zobrazit plný text záznamu

Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy

Autor: M, Shalev, T C, Thompson, A, Frolov, S M, Lippman, W K, Hong, H, Fritsche, D, Kadmon

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 6(10)

The objective of this study was to determine whether there is any beneficial effect of oral 13-cis-retinoic acid (isotretinoin) on prostate cancer, using serum prostate-specific antigen (PSA) levels as a surrogate end point in patients with a rising

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b866cbe9bb83c6b1ae1237a0da60cff2
https://pubmed.ncbi.nlm.nih.gov/11051228

Zobrazit plný text záznamu

Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer

Autor: M, Shalev, D, Kadmon, B S, Teh, E B, Butler, E, Aguilar-Cordova, T C, Thompson, J R, Herman, H L, Adler, P T, Scardino, B J, Miles

Publikováno v: The Journal of urology. 163(6)

We assess risks, toxicity and side effects of multiple and repeat in situ suicide gene therapy in patients with localized prostate cancer.The study population comprised patients with localized prostate cancer receiving multiple and/or repeat intrapro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c3c73330edacd688af5734eacb1bb74c
https://pubmed.ncbi.nlm.nih.gov/10799174

Zobrazit plný text záznamu

Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Study

Autor: G L, Andriole, H A, Guess, J I, Epstein, H, Wise, D, Kadmon, E D, Crawford, P, Hudson, C L, Jackson, N A, Romas, L, Patterson, T J, Cook, J, Waldstreicher

Publikováno v: Urology. 52(2)

To evaluate prostate cancer detection and prostate-specific antigen (PSA) among men with benign prostatic hyperplasia treated with finasteride.Three thousand forty men 45 to 78 years of age with PSA less than 10 ng/mL and no history of prostate cance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::968c7fb23b8c6a57704d502a9fe4abcb
https://pubmed.ncbi.nlm.nih.gov/9697781

Zobrazit plný text záznamu

Pitfalls in interpreting prostate specific antigen velocity

Autor: D, Kadmon, A D, Weinberg, R H, Williams, V N, Pavlik, P, Cooper, P J, Migliore

Publikováno v: The Journal of urology. 155(5)

The concept of prostate specific antigen (PSA) velocity as an improved marker for prostate cancer detection is intriguing. However, before this concept is applied to individual patients several confounding parameters must be addressed. We determined

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a2f066e1238062c13ccf36e998f595c3
https://pubmed.ncbi.nlm.nih.gov/8627848

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání